share_log

YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | SC 13G: Statement of acquisition of beneficial ownership by individuals-Yi ZHANG(42.6%),All Brilliance Investments Limited(41.9%), etc.

YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | SC 13G: Statement of acquisition of beneficial ownership by individuals-Yi ZHANG(42.6%),All Brilliance Investments Limited(41.9%), etc.

YS BIOPHARMA CO LTD C/WTS 15/03/2028 (TO PUR ORD) | SC 13G:超过5%持股股东披露文件-Yi ZHANG(42.6%),All Brilliance Investments Limited(41.9%)等
美股sec公告 ·  02/15 16:30
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息